All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

FDA Approves Axitinib for Advanced Kidney Cancer Patients

January 27th 2012

The FDA approved axitinib for the treatment of patients with advanced RCC who have failed to respond to another drug.

Oral HPV Infections More Prevalent in Men

January 26th 2012

Approximately 7% of Americans carry the human papillomavirus (HPV) in their oral cavities, and men are 3 times more likely to carry the virus than women.

BRCA1 and BRCA2 Mutations Yield Better Prognosis in Ovarian Cancer Patients

January 25th 2012

Patients with ovarian cancer who express BRCA1/2 mutations demonstrated a better overall survival after 5 years.

Electronic Cigarettes

January 25th 2012

Are electronic cigarettes "a miracle" as some users claim, or an unproven-and potentially harmful-smoking cessation aid?

FDA Approves Genzyme's Fabrazyme Plant

January 24th 2012

Genzyme Corporation announced that the FDA has approved its new manufacturing plant in Framingham, Massachusetts.

Bortezomib Approved for Subcutaneous Injection

January 24th 2012

The FDA has deemed subcutaneous injection as a safe and valid method of delivering the drug bortezomib in patients with multiple myeloma.

Researchers Discover Basis for Secondary Skin Cancers in Patients Taking Vemurafenib

January 18th 2012

The molecular basis behind the relatively high incidence of secondary skin cancers after patients received vemurafenib has been discovered.

HER2-Positive Patients Benefit From Combination Therapy of Trastuzumab and Lapatinib

January 17th 2012

Two new studies suggest that dual inhibition of HER2 might serve as a better approach to treating patients with HER2-positive breast cancer.

Updated IV Catheter Infection Prevention Guidelines

January 17th 2012

Every clinician should have this resource at their fingertips.

FDA Issues New Safety Warnings on Brentuximab, Including Risk of Rare Brain Infection

January 13th 2012

The FDA and Seattle Genetics announced that new warning labels would be issued for brentuximab vedotin.

DNA Analysis Finds First Gene Implicated in Prostate Cancer

January 12th 2012

A statistical analysis led to the discovery of the first high-risk genetic mutation associated with hereditary prostate cancer.

Robotic-Assisted Surgery for Prostate Cancer

January 9th 2012

The public may believe it's superior to surgery performed solely by humans, but are they correct?

Tivozanib Demonstrates Better PFS Than Sorafenib, but Failed to Meet Investors Expectations

January 3rd 2012

The investigational drug, tivozanib, showed improved rates of PFS in patients with advanced RCC than the already-approved sorafenib.

Nursing Test Banks

January 3rd 2012

The Internet has made it easy for students to obtain test questions.

Progress in Treating Advanced Breast Cancer

December 13th 2011

Promising study results were released at the San Antonio Breast Cancer Symposium.

ODAC Unanimously Supports Axitinib for Renal Cell Carcinoma

December 8th 2011

ODAC unanimously voted to recommend the approval of axitinib for the second-line treatment of patients with advanced renal cell carcinoma.

What is Thoracic Surgery?

December 8th 2011

"What is Thoracic Surgery?" is a good question.

Stem Cell Donors Now Can Be Paid

December 5th 2011

A federal appeals court decides that stem cells are a renewable tissue.

Adverse Drug Events

November 29th 2011

Four commonly prescribed drugs are responsible for most emergency room visits.

FDA Says Avastin Not Safe or Effective for Patients With Breast Cancer

November 18th 2011

The FDA commissioner announced the withdrawal of its approval for bevacizumab (Avastin) to treat patients with breast cancer.